Stefano Palazzolo

1.8k total citations
24 papers, 1.4k citations indexed

About

Stefano Palazzolo is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Stefano Palazzolo has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Biomedical Engineering and 4 papers in Cancer Research. Recurrent topics in Stefano Palazzolo's work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Extracellular vesicles in disease (5 papers). Stefano Palazzolo is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Extracellular vesicles in disease (5 papers). Stefano Palazzolo collaborates with scholars based in Italy, Ukraine and India. Stefano Palazzolo's co-authors include Flavio Rizzolio, Giuseppe Corona, Giuseppe Toffoli, Mohamad Hadla, Isabella Caligiuri, Vincenzo Canzonieri, Samer Bayda, Pietro Riello, Vinit Kumar and Tiziano Tuccinardi and has published in prestigious journals such as Cancer Research, Chemical Communications and Journal of Controlled Release.

In The Last Decade

Stefano Palazzolo

24 papers receiving 1.4k citations

Peers

Stefano Palazzolo
Bin Du China
Rashi Iyer United States
Jun Shao China
Aaron H. Colby United States
Stefano Palazzolo
Citations per year, relative to Stefano Palazzolo Stefano Palazzolo (= 1×) peers Kejian Shi

Countries citing papers authored by Stefano Palazzolo

Since Specialization
Citations

This map shows the geographic impact of Stefano Palazzolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Palazzolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Palazzolo more than expected).

Fields of papers citing papers by Stefano Palazzolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Palazzolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Palazzolo. The network helps show where Stefano Palazzolo may publish in the future.

Co-authorship network of co-authors of Stefano Palazzolo

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Palazzolo. A scholar is included among the top collaborators of Stefano Palazzolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Palazzolo. Stefano Palazzolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scattolin, Thomas, Dario R. Alessi, Isabella Caligiuri, et al.. (2025). Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy. Dalton Transactions. 54(11). 4685–4696. 4 indexed citations
2.
Palazzolo, Stefano, Isabella Caligiuri, Adriano Sfriso, et al.. (2022). Early Warnings by Liver Organoids on Short- and Long-Chain PFAS Toxicity. Toxics. 10(2). 91–91. 36 indexed citations
3.
Palazzolo, Stefano, Vincenzo Canzonieri, & Flavio Rizzolio. (2022). The history of small extracellular vesicles and their implication in cancer drug resistance. Frontiers in Oncology. 12. 948843–948843. 13 indexed citations
4.
Adeel, Muhammad, Adriano Sfriso, Salvatore Parisi, et al.. (2021). A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor. International Journal of Pharmaceutics. 613. 121374–121374. 3 indexed citations
5.
Scattolin, Thomas, Stefano Palazzolo, Isabella Caligiuri, et al.. (2020). The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer. Chemical Communications. 56(81). 12238–12241. 43 indexed citations
6.
Granchi, Carlotta, Giulia Bononi, Eleonora Gori, et al.. (2020). Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. European Journal of Medicinal Chemistry. 209. 112857–112857. 28 indexed citations
7.
Back, Michele, Davide Cristofori, Jumpei Ueda, et al.. (2020). Upconversion-mediated Boltzmann thermometry in double-layered Bi2SiO5:Yb3+,Tm3+@SiO2 hollow nanoparticles. Journal of Materials Chemistry C. 8(23). 7828–7836. 66 indexed citations
8.
Scattolin, Thomas, Fabiano Visentin, Stefano Palazzolo, et al.. (2020). Palladium(II)‐η3‐Allyl Complexes Bearing N‐Trifluoromethyl N‐Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High‐Grade Serous Ovarian Cancer Tumoroids. Chemistry - A European Journal. 26(51). 11868–11876. 85 indexed citations
9.
Lapillo, Margherita, Stefano Palazzolo, Giulio Poli, et al.. (2019). First-of-its-kind STARD3 Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent. ACS Medicinal Chemistry Letters. 10(4). 475–480. 18 indexed citations
10.
Palazzolo, Stefano, Mohamad Hadla, Isabella Caligiuri, et al.. (2019). An Effective Multi-Stage Liposomal DNA Origami Nanosystem for In Vivo Cancer Therapy. Cancers. 11(12). 1997–1997. 42 indexed citations
11.
Palazzolo, Stefano, Mohamad Hadla, Samer Bayda, et al.. (2019). Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin. ACS Medicinal Chemistry Letters. 10(4). 517–521. 38 indexed citations
12.
Palazzolo, Stefano, Carlotta Granchi, Filippo Minutolo, et al.. (2018). Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer. Journal of Controlled Release. 281. 1–10. 33 indexed citations
13.
Palazzolo, Stefano. (2018). Engineered DNA nanostructures for targeted breast cancer therapy. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 1 indexed citations
14.
Bayda, Samer, Mohamad Hadla, Stefano Palazzolo, et al.. (2017). Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy. Journal of Controlled Release. 248. 144–152. 51 indexed citations
15.
Palazzolo, Stefano, Samer Bayda, Mohamad Hadla, et al.. (2017). The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes. Current Medicinal Chemistry. 25(34). 4224–4268. 156 indexed citations
16.
Kumar, Vinit, Stefano Palazzolo, Samer Bayda, et al.. (2016). DNA Nanotechnology for Cancer Therapeutics. Theranostics. 6(5). 710–725. 112 indexed citations
17.
Rizzolio, Flavio, Mohamad Hadla, Giuseppe Corona, et al.. (2016). Abstract 2205: Exosomal encapsulation of doxorubicin reduces the cardiac toxicity of mice. Cancer Research. 76(14_Supplement). 2205–2205. 3 indexed citations
18.
Hadla, Mohamad, Stefano Palazzolo, Giuseppe Corona, et al.. (2016). Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models. Nanomedicine. 11(18). 2431–2441. 234 indexed citations
19.
Granchi, Carlotta, Flavio Rizzolio, Stefano Palazzolo, et al.. (2016). Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors. Journal of Medicinal Chemistry. 59(22). 10299–10314. 41 indexed citations
20.
Kumar, Vinit, Samer Bayda, Mohamad Hadla, et al.. (2015). Enhanced Chemotherapeutic Behavior of Open‐Caged DNA@Doxorubicin Nanostructures for Cancer Cells. Journal of Cellular Physiology. 231(1). 106–110. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026